Previous 10 |
Apotheca to Fight Opioid Addiction Through Cannabinoid Pain Alleviation Medical Device Seattle, WA. , May 08, 2018 (GLOBE NEWSWIRE) -- Cannabis Leaf (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, formulation and delivery technologies for the healt...
Seattle, WA , April 17, 2018 (GLOBE NEWSWIRE) -- Apotheca Biosciences (PCFP), a developer of cutting-edge medical products, nutraceuticals, formulation and delivery technologies for the healthcare and consumer care industry announces today that the company has developed three core platform ...
SEATTLE, WA, March 29, 2018 (GLOBE NEWSWIRE) -- Cannabis Leaf, Inc., a developer of cutting-edge medical products, nutraceuticals, formulation and delivery technologies for the healthcare and consumer care industry, announces today that on March 4, 2018, an Agreement for Plan of Merger was ...
Denver, CO, March 12, 2018 (GLOBE NEWSWIRE) -- FutureLand Corp. (OTC: FUTL), a leading provider of strategic real estate investment, grow facilities and material solutions to the medical and recreational global cannabis industry, announced today that Apotheca Biosciences was bought by Ca...
News, Short Squeeze, Breakout and More Instantly...
Apotheca Biosciences Inc Company Name:
PCFP Stock Symbol:
OTCMKTS Market:
Ticker Symbol Will be Changed from PCFP to CBDC Saint Petersburg, FL, April 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery technologies fo...
SAINT PETERSBURG, FL, April 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations, and cannabis delivery technologies for the health care and consumer care industry, is pl...
Saint Petersburg, FL, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: PCFP), a biopharmaceutical company, which engages in discovering, developing, and commercializing cannabinoid-based medicines for Opioid crisis, Neuropathic pain, Cancer, Alzheimer's,...